Fidelity Investments’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-884,698
| Closed | -$4.28M | – | 4429 |
|
|
2020
Q1 | $4.28M | Hold |
884,698
| – | – | ﹤0.01% | 1983 |
|
|
2019
Q4 | $9.4M | Buy |
884,698
+202,000
| +30% | +$2.01M | ﹤0.01% | 1870 |
|
|
2019
Q3 | $7.11M | Sell |
682,698
-55,000
| -7% | -$720K | ﹤0.01% | 1943 |
|
|
2019
Q2 | $11.3M | Sell |
737,698
-178,000
| -19% | -$2.57M | ﹤0.01% | 1840 |
|
|
2019
Q1 | $11.8M | Sell |
915,698
-531,100
| -37% | -$6M | ﹤0.01% | 1803 |
|
|
2018
Q4 | $13.7M | Sell |
1,446,798
-106,750
| -7% | -$1.38M | ﹤0.01% | 1694 |
|
|
2018
Q3 | $25.8M | Sell |
1,553,548
-439,493
| -22% | -$7.05M | ﹤0.01% | 1574 |
|
|
2018
Q2 | $32M | Sell |
1,993,041
-1,157,118
| -37% | -$20.7M | ﹤0.01% | 1494 |
|
|
2018
Q1 | $48.2M | Buy |
3,150,159
+1,330,718
| +73% | +$20.7M | 0.01% | 1315 |
|
|
2017
Q4 | $28.4M | Sell |
1,819,441
-182,500
| -9% | -$2.44M | ﹤0.01% | 1555 |
|
|
2017
Q3 | $22.2M | Sell |
2,001,941
-536,951
| -21% | -$5.05M | ﹤0.01% | 1658 |
|
|
2017
Q2 | $23.4M | Hold |
2,538,892
| – | – | ﹤0.01% | 1617 |
|
|
2017
Q1 | $21.7M | Buy |
2,538,892
+1,063,457
| +72% | +$9.69M | ﹤0.01% | 1664 |
|
|
2016
Q4 | $15.8M | Sell |
1,475,435
-385,957
| -21% | -$4.67M | ﹤0.01% | 1779 |
|
|
2016
Q3 | $20.2M | Hold |
1,861,392
| – | – | ﹤0.01% | 1663 |
|
|
2016
Q2 | $12.6M | Sell |
1,861,392
-522
| -0% | -$3.29K | ﹤0.01% | 1864 |
|
|
2016
Q1 | $8.68M | Sell |
1,861,914
-108,687
| -6% | -$531K | ﹤0.01% | 2015 |
|
|
2015
Q4 | $12.4M | Buy |
1,970,601
+108,687
| +6% | +$882K | ﹤0.01% | 1904 |
|
|
2015
Q3 | $16.4M | Buy |
1,861,914
+522
| +0% | +$5.48K | ﹤0.01% | 1725 |
|
|
2015
Q2 | $21.9M | Sell |
1,861,392
-104,500
| -5% | -$1.45M | ﹤0.01% | 1692 |
|
|
2015
Q1 | $28.4M | Buy |
1,965,892
+325,000
| +20% | +$4.97M | ﹤0.01% | 1598 |
|
|
2014
Q4 | $28M | Hold |
1,640,892
| – | – | ﹤0.01% | 1596 |
|
|
2014
Q3 | $20.4M | Hold |
1,640,892
| – | – | ﹤0.01% | 1724 |
|
|
2014
Q2 | $24.1M | Hold |
1,640,892
| – | – | ﹤0.01% | 1711 |
|
|
2014
Q1 | $33.4M | Buy |
1,640,892
+164,900
| +11% | +$4M | ﹤0.01% | 1522 |
|
|
2013
Q4 | $28.9M | Sell |
1,475,992
-49,500
| -3% | -$1.32M | ﹤0.01% | 1570 |
|
|
2013
Q3 | $69.1M | Buy |
1,525,492
+42,536
| +3% | +$1.39M | 0.01% | 1121 |
|
|
2013
Q2 | $35.4M | Buy |
+1,482,956
| New | +$23.6M | 0.01% | 1410 |
|
Fidelity Investments's STML Position: Q2 2020 in Review
Fidelity Investments sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 884,698 shares — an estimated $4.28M sold.
Fidelity Investments first reported a position in STML in Q2 2013 and held it in 28 quarters. The position peaked at $69.1M in Q3 2013. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- Fidelity Investments reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- Fidelity Investments sold 884,698 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $4.28M.
- Fidelity Investments first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and held it in 28 quarters.
- Fidelity Investments's Stemline Therapeutics, Inc. position peaked at $69.1M in Q3 2013.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.